112 related articles for article (PubMed ID: 9302181)
1. Identification of two germline point mutations in the 5'UTR of the androgen receptor gene in men with prostate cancer.
Crocitto LE; Henderson BE; Coetzee GA
J Urol; 1997 Oct; 158(4):1599-601. PubMed ID: 9302181
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
3. Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.
Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
J Urol; 2004 Jan; 171(1):431-3. PubMed ID: 14665948
[TBL] [Abstract][Full Text] [Related]
4. Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor gene mutations in hormone-refractory prostate cancer.
Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T
J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Tilley WD; Buchanan G; Hickey TE; Bentel JM
Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics.
Chen G; Wang X; Zhang S; Lu Y; Sun Y; Zhang J; Li Z; Lu J
Prostate; 2005 Jun; 63(4):395-406. PubMed ID: 15617028
[TBL] [Abstract][Full Text] [Related]
8. R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
Gruber SB; Chen H; Tomsho LP; Lee N; Perrone EE; Cooney KA
Prostate; 2003 Mar; 54(4):306-9. PubMed ID: 12539229
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor mutations in prostate cancer.
Barrack ER
Mt Sinai J Med; 1996; 63(5-6):403-12. PubMed ID: 8898547
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR.
Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S
Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor gene amplification and protein expression in recurrent prostate cancer.
Ford OH; Gregory CW; Kim D; Smitherman AB; Mohler JL
J Urol; 2003 Nov; 170(5):1817-21. PubMed ID: 14532783
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
Taplin ME; Balk SP
J Cell Biochem; 2004 Feb; 91(3):483-90. PubMed ID: 14755679
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.
Kinoshita H; Shi Y; Sandefur C; Meisner LF; Chang C; Choon A; Reznikoff CR; Bova GS; Friedl A; Jarrard DF
Cancer Res; 2000 Jul; 60(13):3623-30. PubMed ID: 10910077
[TBL] [Abstract][Full Text] [Related]
15. Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.
Mononen N; Syrjäkoski K; Matikainen M; Tammela TL; Schleutker J; Kallioniemi OP; Trapman J; Koivisto PA
Cancer Res; 2000 Nov; 60(22):6479-81. PubMed ID: 11103816
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic functional properties of androgen receptor mutants in prostate cancer.
Bergerat JP; Céraline J
Hum Mutat; 2009 Feb; 30(2):145-57. PubMed ID: 18800375
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of the androgen receptor gene a possible role in prostate cancer].
Mowszowicz I; Mestayer C
Bull Cancer; 1997 Feb; 84(2):183-8. PubMed ID: 9180843
[TBL] [Abstract][Full Text] [Related]
18. Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
Waltering KK; Wallén MJ; Tammela TL; Vessella RL; Visakorpi T
Prostate; 2006 Nov; 66(15):1585-91. PubMed ID: 16927275
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
20. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]